• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内镜下炎症和黏膜愈合对溃疡性结肠炎患者健康相关生活质量的影响。

The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients.

作者信息

Theede Klaus, Kiszka-Kanowitz Marianne, Nordgaard-Lassen Inge, Mertz Nielsen Anette

机构信息

Gastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Denmark

Gastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Denmark.

出版信息

J Crohns Colitis. 2015 Aug;9(8):625-32. doi: 10.1093/ecco-jcc/jjv081. Epub 2015 May 8.

DOI:10.1093/ecco-jcc/jjv081
PMID:25956537
Abstract

BACKGROUND

Health-related quality of life [HRQoL] is impaired in ulcerative colitis and is correlated to clinical disease activity. The recent shift towards more objective treatment goals like mucosal healing generates a need for evaluating the association between endoscopic disease activity, mucosal healing and HRQoL.

METHODS

In this cross-sectional study, patients with either active or inactive ulcerative colitis underwent sigmoidoscopy. Clinical disease activity was assessed by the Simple Clinical Colitis Activity Index [SCCAI], endoscopic inflammation by the Mayo Endoscopic Subscore [MES], and HRQoL by the Short Inflammatory Bowel Disease Questionnaire [SIBDQ] and Short Health Scale [SHS].

RESULTS

A total of 110 patients, 71% with active disease, had a median SCCAI score of 3 and a median MES score of 1. Patients in clinical remission had a mean SIBDQ of 60 and SHS of 6. HRQoL decreased significantly with increasing clinical (SIBDQ [χ(2) = 61.8, p < 0.0001] and SHS [χ(2) = 63.4, p < 0.0001]) and endoscopic disease activity (SIBDQ [χ(2) = 33.1, p < 0.0001] and SHS [χ(2) = 40.3, p < 0.0001]). Mucosal healing was associated with a higher HRQoL than active inflammation (59/46, p < 0.0001 [SIBDQ] and 7/20, p < 0.0001 [SHS]). Decreased HRQoL was observed with more extensive disease. Linear regression revealed strong association between SIBDQ and SHS.

CONCLUSIONS

Not only clinical disease activity but also endoscopic inflammation and disease extent were associated with decreased HRQoL. Patients with mucosal healing had significant higher HRQoL, emphasising the importance of this treatment goal. Both SHS and SIBDQ are easy to use and to implement, and were strongly correlated.

摘要

背景

溃疡性结肠炎患者的健康相关生活质量(HRQoL)受损,且与临床疾病活动相关。近期治疗目标转向诸如黏膜愈合等更客观的目标,这就需要评估内镜下疾病活动、黏膜愈合与HRQoL之间的关联。

方法

在这项横断面研究中,活动性或非活动性溃疡性结肠炎患者接受了乙状结肠镜检查。通过简单临床结肠炎活动指数(SCCAI)评估临床疾病活动,通过梅奥内镜子评分(MES)评估内镜下炎症,通过简短炎症性肠病问卷(SIBDQ)和简短健康量表(SHS)评估HRQoL。

结果

总共110例患者,71%患有活动性疾病,SCCAI中位数为3,MES中位数为1。临床缓解的患者SIBDQ平均分为60,SHS平均分为6。HRQoL随着临床(SIBDQ [χ(2)=61.8,p<0.0001]和SHS [χ(2)=63.4,p<0.0001])及内镜下疾病活动(SIBDQ [χ(2)=33.1,p<0.0001]和SHS [χ(2)=40.3,p<0.0001])的增加而显著降低。与活动性炎症相比,黏膜愈合与更高的HRQoL相关(59/46,p<0.0001 [SIBDQ]和7/20,p<0.0001 [SHS])。疾病范围越广,HRQoL越低。线性回归显示SIBDQ与SHS之间存在强关联。

结论

不仅临床疾病活动,而且内镜下炎症和疾病范围均与HRQoL降低相关。黏膜愈合的患者HRQoL显著更高,强调了这一治疗目标的重要性。SHS和SIBDQ均易于使用和实施,且相关性很强。

相似文献

1
The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients.内镜下炎症和黏膜愈合对溃疡性结肠炎患者健康相关生活质量的影响。
J Crohns Colitis. 2015 Aug;9(8):625-32. doi: 10.1093/ecco-jcc/jjv081. Epub 2015 May 8.
2
Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.粪便钙卫蛋白水平与溃疡性结肠炎的内镜和组织学炎症相关,并可识别出黏膜愈合的患者。
Clin Gastroenterol Hepatol. 2015 Nov;13(11):1929-36.e1. doi: 10.1016/j.cgh.2015.05.038. Epub 2015 Jun 4.
3
Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.快速粪便钙卫蛋白水平评估和炎症性肠病问卷(SIBDQ)评分可准确检测临床缓解期炎症性肠病(IBD)患者的活动性黏膜炎症:一项前瞻性研究。
J Gastrointestin Liver Dis. 2014 Sep;23(3):273-8. doi: 10.15403/jgld.2014.1121.233.thv.
4
Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.溃疡性结肠炎患者的预后在黏膜完全愈合和部分愈合的患者之间有所不同,这可以通过血小板计数来预测。
World J Gastroenterol. 2014 Dec 28;20(48):18367-74. doi: 10.3748/wjg.v20.i48.18367.
5
Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?在溃疡性结肠炎中,黏膜愈合是否比临床缓解更常见?——这是事实还是仅仅是研究中的一种误解?
Scand J Gastroenterol. 2015 Aug;50(8):985-90. doi: 10.3109/00365521.2015.1018313. Epub 2015 Mar 2.
6
Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings.由内镜梅奥子评分定义的完全黏膜愈合,通过新型高清结肠镜检查和改良组织学分级仍显示存在异常。
Endoscopy. 2015 Aug;47(8):726-34. doi: 10.1055/s-0034-1391863. Epub 2015 Mar 31.
7
Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.利用粪便免疫化学定量检测评估溃疡性结肠炎的黏膜愈合。
Am J Gastroenterol. 2013 Jan;108(1):83-9. doi: 10.1038/ajg.2012.315. Epub 2012 Sep 25.
8
Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.黏膜愈合作为结肠炎性肠病的治疗靶点及疾病活动度评分方法。
Gastrointest Endosc Clin N Am. 2014 Jul;24(3):367-78. doi: 10.1016/j.giec.2014.03.005. Epub 2014 May 6.
9
Potential utility of a new ulcerative colitis segmental endoscopic index combining disease severity and the extent of inflammation.一种结合疾病严重程度和炎症范围的新型溃疡性结肠炎节段性内镜指数的潜在效用。
J Clin Gastroenterol. 2015 May-Jun;49(5):401-6. doi: 10.1097/MCG.0000000000000199.
10
The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.《简短炎症性肠病问卷:用于社区医生管理炎症性肠病的生活质量工具》。CCRPT研究人员。加拿大克罗恩病复发预防试验。
Am J Gastroenterol. 1996 Aug;91(8):1571-8.

引用本文的文献

1
Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective.原发性硬化性胆管炎患者报告的结局:澳大利亚视角
Aliment Pharmacol Ther. 2025 May;61(10):1612-1621. doi: 10.1111/apt.70054. Epub 2025 Mar 2.
2
Comprehensive assessment of nutritional and functional status of patients with ulcerative colitis and their impact on quality of life.溃疡性结肠炎患者营养与功能状态的综合评估及其对生活质量的影响。
Indian J Gastroenterol. 2024 Feb;43(1):254-263. doi: 10.1007/s12664-024-01539-9. Epub 2024 Feb 23.
3
Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients.
梅奥评分的完全、部分和修正排列:溃疡性结肠炎患者临床及患者报告结局的特征分析
Crohns Colitis 360. 2021 Feb 23;3(1):otab007. doi: 10.1093/crocol/otab007. eCollection 2021 Jan.
4
Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore.奥卡西平维持治疗溃疡性结肠炎患者的 OCTAVE Sustain 基线 Mayo 内镜亚评分分层。
BMC Gastroenterol. 2023 Feb 8;23(1):34. doi: 10.1186/s12876-022-02508-2.
5
Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study.阿达木单抗对中重度溃疡性结肠炎患者疾病负担的影响:为期一年的真实世界 UCanADA 研究。
World J Gastroenterol. 2022 Sep 14;28(34):5058-5075. doi: 10.3748/wjg.v28.i34.5058.
6
Comparing the clinical application values of the Degree of Ulcerative Colitis Burden of Luminal Inflammation (DUBLIN) score and Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in patients with ulcerative colitis.比较溃疡性结肠炎管腔炎症负担程度(DUBLIN)评分与溃疡性结肠炎内镜严重程度指数(UCEIS)在溃疡性结肠炎患者中的临床应用价值。
Gastroenterol Rep (Oxf). 2021 Jul 15;9(6):533-542. doi: 10.1093/gastro/goab026. eCollection 2021 Dec.
7
Ulcerative colitis: STRIDE-ing beyond symptoms with new standards.溃疡性结肠炎:以新标准超越症状的 STRIDE。
Singapore Med J. 2024 Feb 1;65(2):99-105. doi: 10.11622/smedj.2021173. Epub 2021 Nov 26.
8
Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months.戈利木单抗可提高中重度溃疡性结肠炎患者的工作生产力:24 个月前瞻性研究结果。
BMC Gastroenterol. 2021 Apr 12;21(1):161. doi: 10.1186/s12876-021-01747-z.
9
The impact of clinical symptoms and endoscopic and histologic disease activity on health-related quality of life in patients with ulcerative colitis following treatment with multimatrix mesalazine.多基质美沙拉嗪治疗后溃疡性结肠炎患者的临床症状、内镜及组织学疾病活动度对健康相关生活质量的影响
Qual Life Res. 2021 Jul;30(7):1925-1938. doi: 10.1007/s11136-021-02787-4. Epub 2021 Mar 2.
10
The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe.美国和欧洲中重度溃疡性结肠炎患者疾病活动度与患者报告结局的相关性。
BMC Gastroenterol. 2020 Jan 21;20(1):18. doi: 10.1186/s12876-020-1164-0.